Stryker Corporation (SYK) To Go Ex-Dividend on March 31st

Stryker Corporation (NYSE:SYK) declared a quarterly dividend on Wednesday, February 4th. Stockholders of record on Tuesday, March 31st will be given a dividend of 0.88 per share by the medical technology company on Thursday, April 30th. This represents a c) annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Tuesday, March 31st.

Stryker has increased its dividend by an average of 0.1%per year over the last three years and has raised its dividend annually for the last 32 consecutive years. Stryker has a payout ratio of 23.7% meaning its dividend is sufficiently covered by earnings. Analysts expect Stryker to earn $14.83 per share next year, which means the company should continue to be able to cover its $3.52 annual dividend with an expected future payout ratio of 23.7%.

Stryker Price Performance

Shares of NYSE SYK opened at $362.63 on Friday. The stock has a market cap of $138.68 billion, a P/E ratio of 43.17, a P/E/G ratio of 2.11 and a beta of 0.87. The firm’s 50-day simple moving average is $358.65 and its 200 day simple moving average is $371.05. Stryker has a fifty-two week low of $329.16 and a fifty-two week high of $404.87. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66.

Stryker (NYSE:SYK) last released its earnings results on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, beating the consensus estimate of $4.40 by $0.07. The firm had revenue of $7.17 billion for the quarter, compared to analysts’ expectations of $7.12 billion. Stryker had a net margin of 12.92% and a return on equity of 24.41%. Stryker’s quarterly revenue was up 11.4% on a year-over-year basis. During the same quarter last year, the company earned $4.01 EPS. Equities analysts expect that Stryker will post 13.47 EPS for the current year.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.